Chargement des cours...
Prévisions
Aucune donnée d'analyste n'est disponible pour cette entreprise.
Actualités Accéder au fil d'actualités
Azelis increases revenue in first half of 2026 by 3.2%
Azelis reports revenue of EUR 2.17 billion for H1 2026, currency-adjusted +3.2%. Adjusted EBITA rose currency-adjusted by 2.6% to EUR 233 million, while the EBITA margin fell slightly to 10.70%. Profit for the period was EUR 86 million, gross profit EUR 524 million; free cash flow fell 19% to EUR 122 million due to higher working capital. Growth was supported in part by recent acquisitions; the company aims for positive adjusted EBITA growth for the full year but warns of limited visibility due to market volatility. » Plus sur de.investing.com
Azelis launches buyback programme of up to 150,000 shares for management incentives
Azelis has announced a share buyback programme that begins on 27 April 2026 and runs until 8 May 2026 or until 150,000 ordinary shares have been repurchased. The aim is to cover obligations under the long-term incentive plan for management; the volume is capped at a maximum of €1.5m. Purchases will be carried out discreetly on the open market by an independent financial intermediary and the acquired shares will be held as treasury shares. The programme is based on the authorisation granted by the 2021 annual general meeting and is being implemented in accordance with Belgian company law; the company will provide regular updates on progress. » Plus sur de.investing.com
Azelis recovers after share slump despite weak quarterly numbers
Azelis shares jumped strongly on Euronext, largely recouping losses from the previous day. Operating profit for Q4 2025 missed expectations by around 6 percent, the outlook remains vague and only points to uncertain timing for a market recovery. The price rebound also follows disappointments at competitor IMCD, which had earlier weighed on the sector. » Plus sur finanzen.net
Dividendes historiques Dividendes
Tous les indicateurs de dividendes Tous les indicateursDonnées financières de l'entreprise
| (EUR) | juin 2026 | |
|---|---|---|
| Chiffre d'affaires | 2,17Md | - |
| Bénéfice brut | 284,30M | - |
| Bénéfice net | 85,16M | - |
| EBITDA | 238,52M | - |
Données fondamentales
| Indicateur | Valeur |
|---|---|
Capitalisation boursière | 2,95Md€ |
Nombre d'actions | 243,38M |
Plus haut/bas sur 52 semaines | 13,50€ - 6,88€ |
Rendement du dividende | 1,86% |
Dividendes TTM | 0,23€ |
Bêta | 0,54 |
Ratio P/E | 25,83 |
Ratio PEG | −2,69 |
Ratio P/B | 1,04 |
Ratio P/S | 0,72 |
Profil de l'entreprise
Die Azelis Group NV vertreibt Spezialchemikalien und Lebensmittelzutaten in Belgien und international. Das Unternehmen bedient verschiedene Segmente in den Bereichen Biowissenschaften, einschließlich Körperpflege, Pharma, Lebensmittel und Gesundheit, Spezialitäten für Landwirtschaft und Gartenbau, sowie Industriechemikalien und Industriechemikalien, wie z. B. CASE, Gummi- und Kunststoffadditive, Schmiermittel und Metallbearbeitungsflüssigkeiten, Elektronik, Grundstoff- und Feinchemikalien, Textilien, Leder und Papieranwendungen. Die Azelis Group NV wurde 1996 gegründet und hat ihren Hauptsitz in Antwerpen, Belgien. Azelis Group NV ist als Tochtergesellschaft von Akita I S.À R.L. tätig.
| Nom | Azelis Group NV |
| PDG | Anna Bertona |
| Siège social | Antwerp,
vl Belgique |
| Site web | |
| Introduction en bourse | 17/09/2021 |
| Employés | 4.000 |
Deep Dive
Symboles boursiers
| Bourse | Symbole |
|---|---|
Euronext | AZE.BR |
Pnk | AZLGF |
Brussels Stock Exchange | AZE.BR |
Frankfurt | 2R7.F |
Düsseldorf | 2R7.DU |
London | 0AA6.L |
München | 2R7.MU |
Découvrir des actifs
Les actionnaires de Azelis Group NV investissent également dans les actifs suivants
